PPCB
Propanc Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · AU
$1.01
−0.98%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-186.8%
Return on equity
-128.1%
Return on assets
-161.1%
Return on invested capital
0.00x
Asset turnover
-$4.1M
Cash from operations
$0.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026